2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2018 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2015 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 6
As coordinator: 1
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0.2*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 4.067.173 | 227.479 | 1 | ||
2020 | 787.825 | 0 | 275.963 | 1 | ||
2018 | 0 | 7.667.960 | 100.000 | 2 | ||
2015 | 0 | 11.423.899 | 757.375 | 2 |
Total number of partners: 57
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 57
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-01-01 | Encompassing Training in fUnctional Disorders across Europe | ETUDE | participant | 4.067.173 | 12 |
2020-01-01 | HeartBIT_4.0 - Application of innovative Medical Data Science technologies for heart diseases. | HEARTBIT_4.0 | coordinator | 787.825 | 5 |
2018-11-01 | INTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTH | REGIONS4PERMED | participant | 1.677.500 | 6 |
2018-01-01 | Stem-cell based gene therapy for recombination deficient SCID (RECOMB) | RECOMB | participant | 5.990.460 | 17 |
2015-05-01 | A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease | BETA3_LVH | participant | 5.425.113 | 12 |
2015-05-01 | Secondary prEvention of CardiovascUlaR disease in the Elderly trial | SECURE | participant | 5.998.786 | 11 |